Our data showed that in the RPE of human AMD donor eyes graded by the Minnesota Grading System for disease severity (Olsen et al. 2017), HDAC3 activity was significantly reduced (Figure 5A) relative to age‐matched controls, without concurrent changes in HDAC3 protein levels (Figure 5B). The gene discussed is HDAC3; the disease is age-related macular degeneration.